When will data-powered personalized health hit ‘escape velocity’?
Summary
From gadgets that monitor our activity and vital signs, to startups that let us explore our own DNA – there are more technologies than ever for collecting and analyzing personal health data. In reply, the panelists – who included Anne Wojcicki, co-founder of personal genomics startup 23andme; Andrew Litt, chief medical officer for Dell; Jake Leschly president and CEO of biomedical information and analytics company Ingenuity Systems and Aaron Horowitz, CEO of interactive toy company Sproutel – said they mostly agreed that widespread adoption could happen in five years, with some saying valuable but intermittent work could happen even sooner. And she also talked about a recent example in which they helped determine that a specific gene variant was likely not responsible for pancreatic cancer. The traditional path would have involved months of research and potentially millions of dollars, she said, but 23andme’s genomic approach took only a matter of days. Instead of taking a one-size-fits-all approach to drug recommendations, he said, the goal is for physicians to be able to prescribe the medication that is best suited for a patient’s particular genetic profile.
Classifications
AskAI Classifications
LabelsLinked Companies
